Based on the recently performed meta-analyses and genome-wide results, the most robust conclusion is that the minor allele (T) of PTPN22 polymorphism is associated with the presence of anti-AChR Abs and with the absence of thymoma in MG [15], [24], [25]. The gene discussed is PTPN22; the disease is myasthenia gravis.